Verrica Pharmaceuticals Stock (NASDAQ: VRCA) stock price, news, charts, stock research, profile.
You can purchase shares of Verrica Pharmaceuticals (NASDAQ:VRCA) through any online brokerage.
Other companies in Verrica Pharmaceuticals’s space includes: Iterum Therapeutics (NASDAQ:ITRM), SCYNEXIS (NASDAQ:SCYX), CalciMedica (NASDAQ:CALC), Rani Therapeutics Hldgs (NASDAQ:RANI) and Lipocine (NASDAQ:LPCN).
Verrica Pharmaceuticals has a consensus price target of $6.80.
The stock price for Verrica Pharmaceuticals (NASDAQ: VRCA) is $0.8009 last updated November 15, 2024 at 7:05 PM EST.
There are no upcoming dividends for Verrica Pharmaceuticals.
Verrica Pharmaceuticals’s Q3 earnings are confirmed for Monday, November 4, 2024.
There is no upcoming split for Verrica Pharmaceuticals.
Verrica Pharmaceuticals is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.